Long-Term Extension Study Evaluating Extended Release Ropinirole XL (Formerly Referred to as Ropinirole CR) in Patients Who Already Completed Either Study 167 or 164 - Contacts and Locations

Please refer to this study by its ClinicalTrials.gov identifier: NCT00650104

Locations


United States, Arizona
	GSK Investigational Site
	Scottsdale, Arizona, United States, 85259

United States, Arkansas
	GSK Investigational Site
	Little Rock, Arkansas, United States, 72205

United States, California
	GSK Investigational Site
	Fountain Valley, California, United States, 92708
	GSK Investigational Site
	Los Angeles, California, United States, 90033
	GSK Investigational Site
	Oxnard, California, United States, 93030

United States, Connecticut
	GSK Investigational Site
	Fairfield, Connecticut, United States, 06824

United States, Florida
	GSK Investigational Site
	Miami, Florida, United States, 33136
	GSK Investigational Site
	Tampa, Florida, United States, 33606
	GSK Investigational Site
	Panama City, Florida, United States, 32405

United States, Georgia
	GSK Investigational Site
	Augusta, Georgia, United States, 30912

United States, Kansas
	GSK Investigational Site
	Kansas City, Kansas, United States, 66160

United States, Michigan
	GSK Investigational Site
	Traverse City, Michigan, United States, 49684
	GSK Investigational Site
	Grand Rapids, Michigan, United States, 49525

United States, New Jersey
	GSK Investigational Site
	Edison, New Jersey, United States, 08818

United States, Ohio
	GSK Investigational Site
	Dayton, Ohio, United States, 45409

United States, Pennsylvania
	GSK Investigational Site
	Philadelphia, Pennsylvania, United States, 19107
	GSK Investigational Site
	Pittsburgh, Pennsylvania, United States, 15213
	GSK Investigational Site
	Upland, Pennsylvania, United States, 19013
	GSK Investigational Site
	Wynnewood, Pennsylvania, United States, 19096

United States, Texas
	GSK Investigational Site
	Houston, Texas, United States, 77030

Belgium
	GSK Investigational Site
	Hasselt, Belgium, 3500
	GSK Investigational Site
	Roeselare, Belgium, 8800

France
	GSK Investigational Site
	Toulouse Cedex 9, France, 31059

Netherlands
	GSK Investigational Site
	HEERLEN, Netherlands, 6419 PC

Norway
	GSK Investigational Site
	Forde, Norway

Sponsors and Collaborators

GlaxoSmithKline

Investigators


Study Director:	GSK Clinical Trials, MD	GlaxoSmithKline